MAIA Biotechnology Statistics Share Statistics MAIA Biotechnology has 32.99M
shares outstanding. The number of shares has increased by 30.24%
in one year.
Shares Outstanding 32.99M Shares Change (YoY) 30.24% Shares Change (QoQ) 8.86% Owned by Institutions (%) 7.54% Shares Floating 23.88M Failed to Deliver (FTD) Shares 239 FTD / Avg. Volume 0.05%
Short Selling Information The latest short interest is 846.51K, so 2.57% of the outstanding
shares have been sold short.
Short Interest 846.51K Short % of Shares Out 2.57% Short % of Float 2.97% Short Ratio (days to cover) 1.48
Valuation Ratios The PE ratio is -1.89 and the forward
PE ratio is -2.6.
MAIA Biotechnology's PEG ratio is
0.06.
PE Ratio -1.89 Forward PE -2.6 PS Ratio 0 Forward PS 0.9 PB Ratio 12.09 P/FCF Ratio -2.8 PEG Ratio 0.06
Financial Ratio History Enterprise Valuation Currently the Enterprise Value (EV) is not available for MAIA Biotechnology.
EV / Sales n/a EV / EBITDA n/a EV / EBIT n/a EV / FCF n/a
Financial Position The company has a current ratio of 2.65,
with a Debt / Equity ratio of 0.
Current Ratio 2.65 Quick Ratio 2.65 Debt / Equity 0 Debt / EBITDA n/a Debt / FCF n/a Interest Coverage -297491.23
Financial Efficiency Return on Equity is n/a and Return on Invested Capital is n/a.
Return on Equity n/a Return on Assets n/a Return on Invested Capital n/a Revenue Per Employee n/a Profits Per Employee $-1.79M Employee Count 13 Asset Turnover 0 Inventory Turnover n/a
Taxes Income Tax -79.95K Effective Tax Rate 0.34%
Stock Price Statistics The stock price has increased by -31.62% in the
last 52 weeks. The beta is 0.03, so MAIA Biotechnology's
price volatility has been higher than the market average.
Beta 0.03 52-Week Price Change -31.62% 50-Day Moving Average 1.58 200-Day Moving Average 1.77 Relative Strength Index (RSI) 57.95 Average Volume (20 Days) 511,096
Income Statement
Revenue n/a Gross Profit n/a Operating Income -16.96M Net Income -23.25M EBITDA -16.96M EBIT -16.96M Earnings Per Share (EPS) -1.05
Full Income Statement Balance Sheet The company has 9.6M in cash and 0 in
debt, giving a net cash position of 9.6M.
Cash & Cash Equivalents 9.6M Total Debt n/a Net Cash n/a Retained Earnings -87.23M Total Assets 11.05M Working Capital 6M
Full Balance Sheet Cash Flow In the last 12 months, operating cash flow was -15.7M
and capital expenditures 0, giving a free cash flow of -15.7M.
Operating Cash Flow -15.7M Capital Expenditures n/a Free Cash Flow -15.7M FCF Per Share -0.71
Full Cash Flow Statement Margins
Gross Margin n/a Operating Margin n/a Pretax Margin n/a Profit Margin n/a EBITDA Margin n/a EBIT Margin n/a FCF Margin n/a
